Apogee Therapeutics, Inc. ( APGE) - Key Metrics
APGE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.14 | -$0.95 | -$0.95 |
| 2026Q1 | $0 | -$1.06 | -$0.80 | -$0.80 |
| 2025Q4 | $0 | -$1.14 | -$1.03 | -$1.03 |
| 2025Q3 | $0 | -$1.11 | -$0.92 | -$0.92 |
| 2025Q2 | $0 | -$1.13 | -$1.06 | -$1.07 |
APGE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -29.11 |
| 2026Q1 | 0% | -19.85 |
| 2025Q4 | 0% | -18.32 |
| 2025Q3 | 0% | -8.95 |
| 2025Q2 | 0% | -9.61 |
APGE
Price: $134.71
52 week price:
Earnings Per Share: -4.35 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.2 billion